Current Headlines

  1. Boston Scientific Buys EndoChoice for $210M, Expands GI Business

    Boston Scientific has announced a $210 million deal to acquire EndoChoice Holdings, an Atlanta-based medtech specializing in endoscopic imaging systems, single-use devices, and infection control products. 

  2. GE Healthcare Launches Its First Healthcare Accelerator For Emerging Markets

    GE Healthcare is earmarking $50 million to fund five.eight, its first healthcare accelerator, which will support startups that develop promising, low-cost medtech technologies specifically designed for emerging markets.

  3. BrainScope’s Hand-Held Device Diagnoses “Full Spectrum” Of TBI, Headed To U.S. Market

    BrainScope — a medtech specializing in traumatic brain injury (TBI) diagnostic technology that is backed by the U.S. Department of Defense (DOD)— has announced FDA clearance for Ahead 300, a hand-held medical device capable of objectively assessing the likelihood of TBI. 

  4. Big Data, Cybersecurity, Precision Medicine Among Top Priorities For FDA in 2017

    The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) announced recently its top ten regulatory science priorities for 2017. As they were in 2016, "Big Data" and medical device cybersecurity remain as focus areas, with precision medicine and clinical trial design joining the list of priorities for next year.

  5. NIH-Funded Closed-Loop Device Controls Blood Pressure In Emergencies

    Scientists from the University of Texas in Arlington (UTA) have received a $440,670 National Institute of Health (NIH) grant for the continued development of a “closed-loop” blood pressure neurostimulation device for the cardiac care environment.  

  6. Medtronic’s DBS Support Software Gains FDA Approval

    Medtronic plc recently announced U.S. Food and Drug Administration (FDA) clearance of StealthStation Cranial Software as an aid for deep brain stimulation (DBS) lead placement.

  7. NIH Awards $2.3M To Fund Study Of Pancreatic Cancer-Fighting Implant

    The National Institute of Health has awarded a $2.3 million grant to CivaTech, developer of an implantable device that provides targeted radiation treatment for cancer patients.  CivaTech plans to use the grant to fund a clinical study that will evaluate safety and efficacy of the CivaSheet device in patients with pancreatic cancer.

  8. FDA Planning Board Unveil Priorities For Coordinating Center Overseeing Device Evaluation System

    A Planning Board convened by the U.S. Food and Drug Administration (FDA) and the Duke-Margolis Center for Health Policy laid out the initial priorities for the proposed Coordinating Center in charge of the National Evaluation System for Health Technology (NEST).

  9. Philips, Macquarie University, Emory Healthcare Launch Australia’s Remote ICU Monitoring Program

    Royal Philips (NYSE: PHG, AEX: PHI), Macquarie University's MQ Health in Sydney and Emory Healthcare in Atlanta, Georgia (US), today announced the launch of Australia's first - and only - remote intensive care unit (eICU) monitoring program, to improve the outcomes of high risk patients in most need of 'round-the-clock' observation.

  10. Zimmer Biomet: Vanguard System Will "Revolutionize" Total Knee Replacement

    Orthopaedic products manufacturer Zimmer Biomet has unveiled Vanguard Individualized Design (ID), which is touted as a first-of-its-kind total knee arthroplasty (TKA) personalized construct, with dual bearings to better preserve the natural tissues surrounding the knee joint.